NHS faces two-year waits as ADHD and autism referrals surge past capacity

Patients and families experience prolonged distress while awaiting diagnosis; delays prevent access to clinical treatment, specialist school support, and disability benefits.
Diagnosis has become the key that unlocks everything else
Assessment bottlenecks block not just medical treatment but school support and disability benefits.
Mark

So we're talking about nearly a million people waiting for ADHD assessment. That's a staggering number. What changed so suddenly?

Mimi

The change wasn't sudden, but it accelerated sharply after 2020. Better clinical understanding, less stigma, more awareness—but also something structural. Diagnosis became the key that unlocks school support, disability benefits, workplace adjustments. It's not just medical anymore.

Luke

But we should be careful here. The source says referral thresholds lowered, which could mean more people are being referred who might not have met older criteria. That's not necessarily a bad thing if those people genuinely need help, but it's worth naming that we don't have a clear picture of whether the surge reflects real unmet need or shifting definitions.

Mark

The Fonagy report seems to suggest both are happening at once.

Mimi

Exactly. He said unmet needs and over-medicalisation can coexist. More girls and young women are being identified who were historically missed. That's real. But institutional demand—schools needing a diagnosis to provide support, the benefits system requiring one—that's also driving referrals. The diagnosis has become a practical mechanism for access.

Luke

And that's the thing that worries me about the framing. The NHS is genuinely overwhelmed. But we don't know from this reporting whether the bottleneck is because there's suddenly twice as much real need, or because the system has become dependent on diagnosis as a gateway to support that should perhaps be available without it.

Mark

So the waiting lists are a symptom of something deeper—a system that's made diagnosis the only way to unlock help.

Mimi

Yes. And that means when the NHS can't deliver timely assessments, people don't just wait for a label. They wait for treatment, for school accommodations, for financial support. The bottleneck cascades.

Luke

The source material doesn't give us numbers on how many of those waiting people are actually in crisis or distress, or how the wait times are affecting outcomes. We know people are waiting. We don't know the full human cost yet.

  • Nearly one million people in England are caught in a diagnostic queue that averages 64 weeks for ADHD and stretches to official two-year minimums for autism in some NHS boards.
  • Referrals have surged so sharply since 2020 that autism diagnoses in young females rose sevenfold in just two years, exposing an infrastructure that was never designed for this scale.
  • The bottleneck is not merely medical — without a formal diagnosis, children cannot access specialist school support, adults cannot claim disability benefits, and families are left to navigate distress without any institutional anchor.
  • A government-commissioned researcher has found that overdiagnosis concerns and genuine unmet need are not mutually exclusive — both are real, and the NHS is equipped to handle neither at current capacity.
  • Final policy recommendations are expected within weeks, but the structural gap between demand and resource remains vast, and the human cost accumulates daily.

Across England, nearly a million people wait in diagnostic limbo for ADHD or autism assessments, some for more than two years — a crisis born not of failure alone, but of a system overtaken by its own expanding awareness. As stigma has receded and clinical understanding has deepened, the demand for formal recognition has surged far beyond what the NHS was built to absorb. A diagnosis is no longer merely a medical verdict; it has become the key that unlocks school support, disability benefits, and workplace accommodation — making the waiting list not just a health crisis, but a cascading social one.

The NHS has hit a wall. Across England, close to a million people are waiting for ADHD assessments — an average of 64 weeks — while another 295,000 queue for autism diagnosis. Some NHS boards have stopped pretending they can meet demand at all, posting two-year waits as official policy.

The scale of the surge is striking. Between 2020 and 2022, annual autism diagnoses in females aged three to 25 rose from 45 to 320 per 100,000 — not a marginal shift, but a fundamental change in how many people are being identified. The causes are layered: genuine improvements in clinical understanding, particularly for girls and women who were historically overlooked; declining stigma; the disruptions of the pandemic; and growing economic anxiety. But perhaps most consequentially, diagnosis has become the practical gateway to everything else — school accommodations, disability benefits, workplace adjustments. It is not merely a medical label. It is a key.

Peter Fonagy, tasked by the government with understanding these trends, resisted the culture war framing that pits overdiagnosis against belated recognition. His interim conclusion was more unsettling than either camp: both things are true simultaneously. Unmet need and over-medicalisation concerns can coexist in the same system. What was undeniable, he found, was that more people — especially young people — were in genuine distress and seeking help.

The human cost is not abstract. Children sit in classrooms without the formal diagnosis that would trigger support. Adults cannot access medication or therapy. The assessment has become a choke point through which all other help must flow, sending ripple effects across education, welfare, and employment. Fonagy's final recommendations are expected soon, but the harder task — closing the gap between surging demand and a system starved of staff and resources — lies ahead.

The NHS has hit a wall. Across England, nearly a million people are waiting to be assessed for attention deficit hyperactivity disorder. The average wait stretches past a year—64 weeks of limbo before a diagnosis that might unlock treatment, school support, or disability benefits. Another 295,000 are queued for autism assessment. Some NHS boards have simply stopped pretending they can meet demand and have posted minimum two-year waiting times as official policy. The health service is not coping.

The numbers tell a story of a system blindsided by its own success. Over the past six years, referrals for ADHD and autism assessments have surged so sharply that the infrastructure built to handle them has snapped. The rise accelerated dramatically after 2020. Between 2020 and 2022 alone, annual autism diagnoses in males aged three to 25 jumped from 185 per 100,000 to 580. In females, the increase was even steeper—from 45 to 320 per 100,000. These are not marginal shifts. They represent a fundamental change in how many people are being identified as needing assessment.

Why the explosion? The answer is layered. Clinical understanding has genuinely improved. Researchers and clinicians now recognize conditions that were missed or misdiagnosed for decades, particularly in girls and young women, who were historically overlooked. Stigma has declined. Social media and public figures have spoken openly about their diagnoses. The pandemic disrupted routines and exposed vulnerabilities. Economic anxiety has driven more people to seek formal recognition of their struggles. And crucially, diagnosis has become the practical gateway to everything else—school accommodations, disability benefits, workplace adjustments. It is not merely a medical label. It is a key that unlocks access to support across multiple systems.

Peter Fonagy, a government-commissioned researcher tasked with understanding these trends, published an interim report earlier this year that refused to pick a side in the culture war raging around the issue. Some dismiss the surge as fashionable overdiagnosis, a product of woke excess. Others celebrate it as the belated recognition of real conditions affecting real people. Fonagy's conclusion was simpler and more unsettling: both things are true. "Unmet needs, misdiagnosis and concerns about over-medicalisation can coexist in the same system," he wrote. What was undeniable was that more people were in distress, especially younger people, and more were seeking help. Referral thresholds had lowered. The NHS, starved of staff and resources, was simply not equipped to absorb the wave.

The human cost is not abstract. Families wait two years for answers. Children sit in classrooms without the formal diagnosis that would trigger school support. Adults cannot access medication or therapy. The bottleneck does not just delay medical treatment—it blocks access to specialist support in schools, to disability benefits, to the formal recognition that allows people to function. The assessment becomes a choke point through which all other help must flow. When the NHS cannot deliver timely assessments, the knock-on effects ripple across education, welfare, and employment.

Fonagy is expected to deliver his final recommendations within weeks. The diagnosis of the problem is clear: the NHS faces a structural mismatch between demand and capacity, driven by genuine increases in need, improved awareness, and the role of formal diagnosis as a gateway to support. The harder task lies ahead—figuring out how to fix it without simply turning people away or pretending the need does not exist.

Unmet needs, misdiagnosis and concerns about over-medicalisation can coexist in the same system
— Peter Fonagy, government-commissioned researcher
More people were experiencing distress, especially younger people, and more people were seeking help as a result
— Peter Fonagy's interim report
Quer a matéria completa? Leia o original em The Guardian ↗
Fale Conosco FAQ